Realcan Pharmaceutical Group Co 002589.SZ · CNY

Its shares trade on Shenzhen under the ticker 002589.SZ. It has been listed since 10 June 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥7.30bn and net income of CN¥16.1m. At that date it held total assets of CN¥14.37bn and shareholders' equity of CN¥5.30bn.

Realcan Pharmaceutical Group Co., Ltd.. engages in the provision of medical services. The company is headquartered in Yantai, Shandong. The company went IPO on 2011-06-10. The firm operates its businesses through three segments. The Medical segment is engaged in the provision of Chinese medicine materials, Chinese medicine tablets, Chinese patent medicines, chemical drug materials, chemical preparations, antibiotics, biochemical pharmaceuticals, biological products, psychotropic substances, anesthetic medicines and peptide hormones. The Equipment is engaged in the provision of medical equipment. The Mobile Medical segment is engaged in the provision of medical and logistics services and mobile medical information services. The firm conducts its businesses mainly within domestic markets, with Shandong as its main market.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Xu HanChairman of the Board, President, since 2009CN¥580,400
• Ms. Yun FengChief Financial Officer, Vice PresidentCN¥423,600
• Mr. Zhe LiVice President, Secretary of the Board, Director, since 2019CN¥403,500
• Mr. Chunlin HanVice President, Director, since 2019CN¥904,400
• Mr. Bo YangVice President, Director, since 2016CN¥366,400
• Mr. Mingtao YanVice PresidentCN¥425,100
• Ms. Liyan WuDirectorCN¥295,400
• Mr. Shoukai ZhangDirector, since 2019CN¥339,800
• Mr. Xijun LiuIndependent DirectorCN¥60,000
• Mr. Kaoxiang SunIndependent DirectorCN¥60,000
• Mr. Jifa WangIndependent DirectorCN¥60,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.